Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedAdded Sarah Cannon Research Institute at Mary Crowley as a recruitment site and removed Mary Crowley Cancer Research as a recruitment site. The update also includes a December 2025 Last Update Posted (Estimated) timestamp.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLocation sections were added for California, Connecticut, Massachusetts, Tennessee, Texas, Wisconsin, New South Wales, and Victoria. The corresponding location sections for those areas were removed in the prior revision.SummaryDifference0.8%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision label was updated from Revision: v3.2.0 to Revision: v3.3.2. There are no visible changes to study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check47 days agoChange DetectedThe notice about government funding status has been removed from the page; this change does not affect the study data or how a user would interact with the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedUpdated the trial site entry from 'Tainan City, Taiwan, 73657' to 'Tainan, Taiwan, 73657' to reflect the correct municipality name.SummaryDifference0.0%

- Check69 days agoChange DetectedThe two screenshots show the same study page with identical content; no additions, deletions, or updates to the study details or locations.SummaryDifference0.4%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.